NOVATO, Calif., Sept. 11 /PRNewswire-FirstCall/ -- Raptor Pharmaceuticals Corp. (OTC Bulletin Board: RPTP.OB - News), today announced that its wholly-owned subsidiary, Raptor Pharmaceutical Inc. (“Raptor”), has formally established its Medical and Scientific Advisory Board. Board members will provide Raptor’s business team with scientific, medical, strategic and business input into its research and development programs.
